This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Osamu Ichihara: Innovator in Cancer Treatment
Introduction
Osamu Ichihara is a notable inventor based in Didcot, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development of compounds that target abnormal cell growth.
Latest Patents
Ichihara holds 1 patent for his work on compounds for treating cancer. His patent describes compounds of general formula (I), wherein R, R, R, R, R, R, X, and Y are defined as inhibitors of Bcl-2. These compounds are particularly useful for treating diseases characterized by abnormal cell growth and/or dysregulated apoptosis.
Career Highlights
Osamu Ichihara is currently employed at Boehringer Ingelheim International GmbH, where he continues to advance his research in the pharmaceutical industry. His work has been instrumental in developing new therapeutic strategies for cancer treatment.
Collaborations
Ichihara has collaborated with esteemed colleagues, including Stephen East and Mark Whittaker, to further enhance the impact of his research in the field.
Conclusion
Osamu Ichihara's innovative work in cancer treatment exemplifies the vital role of inventors in advancing medical science. His contributions are paving the way for new therapeutic options for patients facing challenging health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile